Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Torii

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Torii's Japan sales performance.

Merck strengthens KRAS stake with Taiho and Astex partnership

Merck strengthens KRAS stake with Taiho and Astex partnership Otsuka’s Taiho has retained co-commercialisation rights in Japan, with the option to promote in certain areas of South East Asia.

Wave’s challenge to Sarepta in Duchenne falls flat

Wave’s challenge to Sarepta in Duchenne falls flat The demise of Wave’s programmes leaves Japan’s Nippon Shinyaku Pharma as the main rival to Sarepta in DMD.

House Democrats finally pass landmark drug pricing bill

House Democrats finally pass landmark drug pricing bill the average price levied in six index countries – including Australia, Canada, France, Germany, Japan and the UK.

The 2019 CPhI Pharma Index Report

The 2019 CPhI Pharma Index Report 2019 saw Japan (7.97) rise above Germany (7.85) into the number one spot for API manufacturing, thanks to a small yet significant 2.5% score increase from the previous ... Finished product manufacturing. Similarly to API manufacturing and Innovativeness,

Novartis highlights emerging assets and late-stage pipeline at R&D day

Novartis highlights emerging assets and late-stage pipeline at R&D day This means that Novartis has plans to make 80 significant submissions to regulators for drug approvals from 2020-2022 in the US, Europe, Japan and China.

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics